29/10/2024
While Ozempic® and Wegovy® contain semaglutide that acts on the GLP-1 receptor and aid weight loss alongside healthy habits, Mounjaro® goes a step further. It contains tirzepatide, which stimulates both the GLP-1 and GIP receptors. This dual-action approach has demonstrated greater potential for weight loss compared to medications that only target the GLP-1 receptor.
0 out of 0 found this helpful